Cite

HARVARD Citation

    Albassam, F. et al. (2020). Rituximab in children with myelin oligodendrocyte glycoprotein antibody and relapsing neuroinflammatory disease. Developmental medicine & child neurology. pp. 390-395. [Online]. 
  
Back to record